Simultaneous Mapping and Quantitation of Ribonucleotides in Human Mitochondrial DNA
November 14th, 2017
9.7K views
Here we describe a method amenable to simultaneously quantitate and genome-wide map ribonucleotides in highly intact DNA at single-nucleotide resolution, combining enzymatic cleavage of genomic DNA with its alkaline hydrolysis and subsequent 5´-end sequencing.
Overview
This study presents a method to simultaneously quantitate and genome-wide map ribonucleotides in highly intact DNA at single-nucleotide resolution. The technique combines enzymatic cleavage of genomic DNA with alkaline hydrolysis and subsequent 5´-end sequencing.
Key Study Components
Area of Science
- Genomics
- Molecular Biology
- DNA Repair Mechanisms
Background
- Understanding ribonucleotide incorporation in DNA is crucial for studying DNA integrity.
- Ribonucleotides can affect DNA replication and repair mechanisms.
- Defects in these processes are linked to various diseases.
- This method can be applied to both mitochondrial and nuclear DNA.
Purpose of Study
- To map the location of incorporated ribonucleotides in human mitochondrial DNA.
- To quantitate the number of ribonucleotides present in the DNA.
- To provide insights into DNA integrity and its implications for disease.
Methods Used
- Enzymatic digestion of genomic DNA using HincII.
- Purification of DNA using paramagnetic beads.
- Hybridization and ligation reactions for DNA preparation.
- PCR amplification to generate sufficient DNA for sequencing.
Main Results
- The method successfully identifies the location of ribonucleotides at single-nucleotide resolution.
- Quantitative analysis reveals the number of ribonucleotides in mitochondrial DNA.
- Insights gained can inform on DNA replication and repair mechanisms.
- The technique is adaptable for use in other model organisms.
Conclusions
- This method enhances understanding of ribonucleotide incorporation in DNA.
- It provides a valuable tool for studying DNA integrity and associated diseases.
- Future applications may extend to various genomic studies.
Frequently Asked Questions
What is the main advantage of this method?
The method allows for simultaneous mapping and quantitation of ribonucleotides in DNA.
Can this method be applied to other organisms?
Yes, it can be adapted to study nuclear DNA and ribonucleotide content in other model organisms.
What are ribonucleotides and why are they important?
Ribonucleotides are building blocks of RNA that can be mistakenly incorporated into DNA, affecting its integrity and function.
How does this method contribute to understanding diseases?
By elucidating the role of ribonucleotides in DNA integrity, it may help identify mechanisms underlying various diseases.
What type of DNA was used in this study?
The study utilized human mitochondrial DNA isolated from HeLa cells.
What is the significance of single-nucleotide resolution?
Single-nucleotide resolution allows for precise mapping of ribonucleotides, providing detailed insights into DNA structure and function.
Executive Industry Relevance
This method enables simultaneous mapping and quantitation of ribonucleotides in human mitochondrial DNA, addressing a critical gap in DNA integrity assessment. By providing single-nucleotide resolution and absolute quantification, it supports mechanistic de-risking in target validation and preclinical model development. The approach enhances predictive confidence in studying replication and repair mechanisms linked to mitochondrial dysfunction and disease.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of ribonucleotide incorporation patterns to clarify mechanisms of DNA replication and repair.
- Operational Value: Provides quantitative readouts that support functional target validation and biological de-risking of nucleic acid metabolism pathways.
Screening & Assay Development
- Scientific Value: Generates normalized read counts that serve as quantitative endpoints for assessing ribonucleotide levels across experimental conditions.
- Operational Value: Utilizes standardized enzymatic digestion and ligation workflows compatible with next-generation sequencing platforms for reproducible assay development.
Translational & Preclinical Research
- Scientific Value: Links ribonucleotide distribution to mitochondrial genome integrity, supporting disease-relevant system modeling.
- Operational Value: Enables longitudinal monitoring of DNA lesion accumulation as a biomarker for preclinical safety and efficacy evaluation.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through preclinical development by providing quantitative DNA integrity data that informs go/no-go decisions.
- Discovery Biology: Supports hypothesis testing on ribonucleotide-induced replication stress and repair pathway activation.
- Screening: Delivers assay-ready, normalized quantitative outputs for compound effect assessment on DNA incorporation rates.
- Analytics: Produces strand-specific, genome-normalized ribonucleotide frequencies enabling cross-condition comparison and statistical analysis.
- Translational Research: Connects mitochondrial DNA ribonucleotide load to functional outcomes in preclinical models of metabolic and neurodegenerative disorders.
- Enterprise Reuse: Establishes a reusable sequencing-based platform for mapping various DNA lesions convertible to 5´-OH or 5´-phosphate ends.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in DNA integrity studies by providing direct, quantifiable measures of ribonucleotide incorporation.
- Operational Value: Ensures reproducibility through standardized enzymatic cleavage, alkaline hydrolysis, and adapter ligation steps.
- Strategic Value: Improves capital efficiency by enabling early detection of genotoxic liabilities in lead optimization.
- Portfolio Impact: Informs risk-adjusted advancement decisions by quantifying mitochondrial DNA damage burden linked to therapeutic candidates.
Implementation Considerations
- Requires expertise in molecular biology, enzymatic DNA manipulation, and next-generation sequencing library preparation.
- Dependent on access to restriction enzymes (e.g., HincII), paramagnetic bead purification systems, and thermal cyclers.
- Necessitates cross-team standardization of DNA quality controls and normalization protocols to mitigate strand bias.
- Adaptation to nuclear DNA or other organisms requires validation of reference genome availability and adjustment of input DNA quantities.
- Practical limitations include the need for highly intact DNA to prevent confounding double-strand breaks during library preparation.
Biopharma FAQs
Why does quantitating ribonucleotides matter for target validation?
Quantitating ribonucleotides provides a direct measure of DNA replication fidelity and repair capacity, which are critical for validating targets involved in genome maintenance pathways. This enables mechanistic de-risking by linking target modulation to measurable changes in nucleic acid integrity.
How does isolating the HincII cleavage site support discovery pipeline applications?
Isolating reads at the HincII recognition site provides an internal control for normalization, enabling accurate quantification of ribonucleotide-induced breaks across samples. This supports reproducible assay development and reliable comparison of experimental conditions in screening campaigns.
What do quantitative dependent variable measurements enable in this context?
Quantitative measurements of ribonucleotide frequency per kilobase enable statistical comparison between treatment groups, helping identify compounds that alter nucleotide pool balance or DNA polymerase fidelity. These data support go/no-go decisions based on genotoxic risk profiles.
Why are replication requirements important for cross-functional collaboration?
Replication ensures that ribonucleotide mapping and quantitation results are consistent across laboratories and sequencing runs, which is essential for building confidence in preclinical data packages. Standardized protocols allow toxicology, pharmacology, and medicinal chemistry teams to interpret data uniformly.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to normalize read counts to internal controls (HincII sites), adjust for strand-specific nucleotide composition, and calculate ribonucleotide frequency per 1,000 bases. These capabilities enable generation of quantitative endpoints suitable for t-tests, ANOVA, or regression analysis in experimental datasets.
Chapters in this video
0:05
Title
0:55
HincII Treatment and Alkaline Hydrolysis
4:11
5'-End Phosphorylation
5:21
Single Strand DNA Ligation
6:35
Second Strand Synthesis
8:23
PCR Amplification, Library Analysis and Pooling
10:10
Results: Simultaneous Quantitation and Genome-wide Mapping of Ribonucleotides
11:39
Conclusion
